Evidence map›Paper›PMID 41146643›Full record

ReviewNew microbes and new infections2025

Bloodstream infections in Cameroon: a systematic review and meta-analysis.

Moise Matakone, Sen Claudine Henriette Ngomtcho, Patrice Landry Koudoum, Isaac Dah, Ravalona Jessica Zemtsa, Michel Noubom

Abstract readReview
In one paragraph

Review in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Moise MatakoneDepartment of Microbiology, Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Sen Claudine Henriette NgomtchoDepartment of Microbiology, Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Patrice Landry KoudoumDepartment of Microbiology, Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Isaac DahThe National Veterinary Laboratory (LANAVET), Yaoundé, Cameroon.
Ravalona Jessica ZemtsaDepartment of Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Michel NoubomDepartment of Microbiology, Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bloodstream infections (BSIs) are significantly associated with morbidity and mortality worldwide, and particularly in low-resource settings. We determined the prevalence of BSIs, profile, and antimicrobial resistance of the causing bacteria in Cameroon. Methods: PubMed, Google Scholar and ScienceDirect databases were searched to identify relevant studies. The random or fixed effect model was used depending on the level of heterogeneity among studies for pooling estimates after the variance was stabilised through the Freeman-Tukey double arcsine transformation. Begg's and Egger's tests were used to quantify publication bias. The protocol was registered in PROSPERO (CRD42023482760). Results: The analysis of 5680 blood cultures from ten studies revealed an overall bacterial BSI prevalence of 25.2 % (95 % CI: 18.1-33.2 %) and 17.2 % (11.6-23.7 %) when the potential contaminants were removed. The leading BSI-causing bacteria were Conclusion: This study reports a substantial prevalence of BSI and resistance to the commonly used antibiotics. It also points out the lack of compliance with international guidelines in microbiological analysis. This highlights the need to empower laboratories' capacities and conduct BSI surveillance across the country to develop more targeted strategies for the prevention, management and treatment of BSIs.

Indexed as

Antimicrobial resistanceBloodstream infectionsEscherichia coliKlebsiellaPriority pathogensStaphylococcus aureus

Identifiers

PMID41146643
PMCPMC12554137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.